Melisron CEO Ofir Sarid Takes Medical Leave; CFO to Step In

Ofir Sarid, the CEO of Israeli real estate company Melisron, has begun an indefinite medical leave of absence. During his absence, the company's Chief Financial Officer will assume his responsibilities.

The article also touches upon various other financial and business news items, including positive trial results for a Celiac disease treatment by Teva Pharmaceuticals, leading to a stock increase. Separately, Ze'ev Singer commented on an investigation into Simad, vowing to prosecute those responsible. In a real estate dispute, Zen is demanding at least $3.7 billion for its evacuation, a move described by Shimhon as an attempt to prevent its closure.

Additional segments cover investment opportunities in Poland, a guide to the S&P 500 for Israeli investors, and an explanation of index funds for bank stocks. The report notes six record highs for the dollar-shekel exchange rate over the last 30 years. A rare apartment opposite the Western Wall is listed for sale at 50 million shekels by its 91-year-old owner. The article also mentions guests of Omer Adam, including a Haredi businessman and a president suspected of receiving millions from him. In consumer news, 38 apartment buyers in Netanya are suing, claiming they were promised they wouldn't need to complete their deals. A critical view on the education system suggests that even high scores in math and computer science are insufficient, calling it a "waste of time" where students learn nothing. Lastly, the article highlights the widespread use of a particular app in Israel, noting the disruption caused when it was blocked.